Emerging therapeutic targets for osteoporosis-Reference-Cited by-同舟云学术

Emerging therapeutic targets for osteoporosis

Published:2020-02-01 Issue:2 Volume:24 Page:115-130
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Gennari Luigi¹,Merlotti Daniela¹,Falchetti Alberto²^ORCID,Eller Vainicher Cristina³,Cosso Roberta⁴,Chiodini Iacopo²^ORCID

Affiliation:

1. Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy

2. Unit for Bone Metabolism Diseases and Diabetes & Lab of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy

3. Endocrinology and Diabetology Units, Department of Medical Sciences and Community, Fondazione Ca’Granda Ospedale Maggiore Policlinico IRCCS, Milan, Italy

4. EndOsMet Villa Donatello Private Hospital, Florence, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1726889

Reference170 articles.

1. Osteoporosis

2. Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

3. Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

4. Bone Quality — The Material and Structural Basis of Bone Strength and Fragility

5. Bone remodelling: its local regulation and the emergence of bone fragility

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. New molecular aspects of the pathogenesis of osteoporosis – perspectives for early diagnosis and treatment;Modern Rheumatology Journal;2024-04-22

3. Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity;Frontiers in Pharmacology;2024-04-02

4. Effect and mechanism of recombinant human fibroblast growth factor 18 on osteoporosis in OVX mice;Climacteric;2024-01-26

5. Metabolic bone disorders and the promise of marine osteoactive compounds;Cellular and Molecular Life Sciences;2023-12-20